St. Luke's Episcopal Health System opened Houston's first CyberKnife® facility in August 2009. This state-of-the-art facility is home to a leading edge technology that is able to precisely care for a variety of medical conditions that may be unable to be treated with traditional surgical options.

 

CyberKnife® technology, developed by Accuray, is used to treat cancerous and non-cancerous tumors in one to four treatments, spaced one or two days apart. This greatly reduces the length of treatment plans for patients who would otherwise be treated with a linear accelerator. Linear accelerator treatments typically require more procedural visits over a duration of six to eight weeks.

The facility also houses the latest in linear accelerator technology, the Varian Trilogy system. The Trilogy is the first of a new generation of cancer care systems, optimized for providing multiple forms of treatment, including radiation therapy and radiosurgery. Use of the Trilogy system has decreased the number of patient visits significantly when compared to traditional radiation protocols.

The project team of St. Luke's Capital Projects, Milestone Project Management, m-Architects, SSR Engineers and JE Dunn Construction was able to exceed the strategic goals of the project by delivering the project for less than the budgeted amount and one month earlier than scheduled.

 

 

8 - Months in the original construction schedule. The project was delivered in seven months!

10,071 - The number of cubic yards of concrete poured into the three vaults, weighing an estimated 3.75 million tons.

2001 - The year that CyberKnife® technology was approved by the USDA.

300 - The number of cities where Accuray's CyberKnife® system is treating patients. 100 of these cities are in the United States.